AzTrials
AzTrials

StrokeBRAIN-WALKNCT07081308

Brain-computer Interface With Plantar Pneumoorthoses for Post-stroke Rehabilitation

A study testing NIRS-BCI-pneumoorthesis in people with Stroke, run by Research Center of Neurology, Russia at 1 site in Russia.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

STUDY PURPOSE The investigators are testing a new rehabilitation system that helps stroke patients recover their ability to walk and think more clearly. This system, called brain-computer interface with plantar pneumorthoses, uses brain signals to control a special device that provides gentle pressure to the feet… Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Stroke
What is being tested?
NIRS-BCI-pneumoorthesis
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteRussia
Study dates
5 Oct 2024to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18-80 years
  • Primary or recurrent supratentorial ischemic stroke
  • Stroke onset 7 days to 24 months
  • Moderate to mild post-stroke lower limb motor impairments
  • Clinical stability
  • Voluntary participation and signing of informed consent

Who cannot join

  • Severe cognitive impairments preventing instruction compliance
  • Sensory or severe motor aphasia
  • Severe visual impairments
  • Lower limb contractures
  • Inability to maintain sitting position

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Roman Kh Lyukmanov, PhD contact

+74953747776

xarisovich@gmail.com

Olesya Al Mokienko, PhD contact

+74953747776

o.mokienko@ihna.ru

Russia1 site, 1 recruiting
  • Russian center of Neurology and Neurosciences

    Moscow, 117485

    Roman Kh Lyukmanov, PhD, 4953747776, xarisovich@gmail.com

    Olesya Al Mokienko, PhD, +74953747776, o.mokienko@ihna.ru

    Recruiting

Other trials in Russia

About this study

Official title: Clinical Evaluation of a Brain-computer Interface Integrated With Plantar Pneumoorthoses for Motor and Cognitive Rehabilitation in Stroke Survivors

STUDY PURPOSE The investigators are testing a new rehabilitation system that helps stroke patients recover their ability to walk and think more clearly. This system, called brain-computer interface with plantar pneumorthoses, uses brain signals to control a special device that provides gentle pressure to the feet, similar to what you feel when walking. The goal is to help patients regain walking skills, improve memory and thinking, and feel better emotionally.

STUDY QUESTIONS

Read more

The main questions the study aims to answer are:

Whether the investigated technology can improve walking in post-stroke patients? Whether the training to control the technology can improve cognitive function in post-stroke patients?

HOW THE STUDY WORKS The investigators compare two groups - one using the new system, another group receiving standard rehabilitation therapy.

Up to 15 patients will try the new system: 10 sessions, each lasting 12 minutes (about 2 weeks, Monday-Friday).

WHAT HAPPENS DURING TREATMENT?

The equipment includes:

Brain monitoring device: Safe infrared light sensors placed on the patient's head (like a cap) Computer software: Reads brain signals when the patient thinks about walking Foot device: Special pneumatic shoes that provide gentle pressure to the patient's feet Screen: Shows visual feedback during training.

What the patient will do:

Sit comfortably in a chair with special shoes on their feet, Complete the task: imagine walking or relax when instructed, What the patient will experience: They will see colors change on the screen and feel gentle pressure on their feet.

Read the detailed description

INTERVENTION NIRS-BCI-Korvit System Components: NIRScout hardware-software complex (16 light sources, 8 detectors); Software for brain activity classification; Korvit pneumoorthesis for plantar support load reproduction; 22-inch monitor for task demonstration Training Procedure: Patient seated with lower limbs fixed in pneumatic orthoses; Task: kinesthetically imagine walking or relax; Feedback: visual (color change on screen) and tactile (support load through orthosis).

Training structure: 16 blocks alternating walking imagination and relaxation/ ASSESSMENT

Motor Function:

  • Fugl-Meyer Scale for Lower Extremity (maximum 34 points, clinically significant improvement ≥6 points);
  • 10-meter Walk Test (clinically significant improvement ≥0.16 m/s);
  • Timed Up and Go Test (clinically significant improvement ≥3 seconds).

Cognitive Functions and Emotional State:

  • Addenbrooke's Cognitive Examination III (ACE III);
  • Hospital Anxiety and Depression Scale (HADS). EXPECTED OUTCOMES.

The study aims to confirm the effectiveness of NIRS-BCI combined with plantar support load simulator for:

  • Gait restoration;
  • Cognitive function improvement;
  • Emotional state normalization in post-stroke patients SAFETY The procedure is safe and poses no health risks. Possible minor fatigue after sessions. The study can be discontinued at any stage upon patient request or if adverse effects occur.

INNOVATION This research represents a novel approach combining non-invasive brain-computer interface technology with proprioceptive feedback systems for comprehensive post-stroke rehabilitation, addressing both motor and cognitive recovery simultaneously

Conditions
Stroke
Being tested
NIRS-BCI-pneumoorthesis
Keywords
Brain-computer interface, Near infrared spectroscopy, gait recovery, stroke rehabilitation, Neurobiofeedback
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NIRS-BCI-pneumoorthesisDevice

    Also called neurobiofeedback

    Patients recieve 10 NIRS-BCI-pneumoorthesis trainings of 16 minutes each over 2 weeks.

    NIRS-BCI-pneumoorthesis Components: NIRScout hardware-software complex (16 light sources, 8 detectors); Software for brain activity classification; Korvit system for plantar support load reproduction; 22-inch monitor for task demonstration.

    Training Procedure: Patient seated with lower limbs fixed in pneumatic orthoses; Task: kinesthetically imagine walking or relax; Feedback: visual (color change on screen) and tactile (support load through orthosis).

    Training structure: 16 blocks alternating walking imagination and relaxation

Study groups in NCT07081308
Study groupRoleWhat they receive
BCIExperimentalStroke patients receiving NIRS-BCI-pneumoorthesis training in combination with standard therapy
Receives: Device: NIRS-BCI-pneumoorthesis
ControlNo interventionStroke patients receiving standard therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Walking speed change as assessed by the 10-Meter Walk Test

    Before and after treatment course

    Measured: From enrollment to the end of treatment at 2 weeks

  2. Lower extremity functional improvement as assessed by the Fugl-Meyer Assessment

    Before and after treatment course

    Measured: From enrollment to the end of treatment at 2 weeks

Secondary outcomes (2)
  1. Lower extremity functional improvement as assessed by the Timed Up and GO test

    Before and after treatment course

    Measured: From enrollment to the end of treatment at 2 weeks

  2. Cognitive function improvement as assessed by the Addenbrooke's cognitive examination - III

    Before and after treatment course

    Measured: "From enrollment to the end of treatment at 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2025
  2. Study start5 Oct 2024
  3. Primary completion30 Oct 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07081308
Sponsor's protocol ID
NIRS-BCI-Korvit
Acronym
BRAIN-WALK
Status last verified
Jul 2025
First submitted
8 Jul 2025
Last updated
28 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing NIRS-BCI-pneumoorthesis in people with Stroke, run by Research Center of Neurology, Russia at 1 site in Russia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Roman Kh Lyukmanov, PhD (+74953747776, xarisovich@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Walking speed change as assessed by the 10-Meter Walk Test (time frame: From enrollment to the end of treatment at 2 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in